NCT03812172View on ClinicalTrials.gov

Screening for Cardiac Amyloidosis with Nuclear Imaging for Minority Populations

Active, not recruitingOBSERVATIONAL
Enrollment

650

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

June 12, 2024

Study Completion Date

April 30, 2025

Conditions
Amyloid Cardiomyopathy, Transthyretin-Related
Interventions
DRUG

99mTc-PYP or 99m Tc-HDP

10-25 mCi of 99mTc-PYP (or 99m Tc-HDP) will be administered intravenously and imaging will be performed after 3 hours.

Trial Locations (4)

10032

Columbia University Irving Medical Center, New York

10037

Harlem Hospital, New York

06519

Yale University/Yale New Haven Medical Center, New Haven

02118

Boston Medical Center/Boston University Medical Center, Boston

Sponsors

Collaborators (1)

Boston Medical Center
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Boston Medical Center

OTHER

collaborator

Harlem Hospital Center

OTHER

collaborator

The Scripps Research Institute

OTHER

collaborator

Yale University

OTHER

lead

Mathew S. Maurer, MD

OTHER